A national survey of physician-assisted suicide and euthanasia in the United States

The New England Journal of Medicine
D E MeierC K Cassel

Abstract

Although there have been many studies of physician-assisted suicide and euthanasia in the United States, national data are lacking. In 1996, we mailed questionnaires to a stratified probability sample of 3102 physicians in the 10 specialties in which doctors are most likely to receive requests from patients for assistance with suicide or euthanasia. We weighted the results to obtain nationally representative data. We received 1902 completed questionnaires (response rate, 61 percent). Eleven percent of the physicians said that under current legal constraints, there were circumstances in which they would be willing to hasten a patient's death by prescribing medication, and 7 percent said that they would provide a lethal injection; 36 percent and 24 percent, respectively, said that they would do so if it were legal. Since entering practice, 18.3 percent of the physicians (unweighted number, 320) reported having received a request from a patient for assistance with suicide and 11.1 percent (unweighted number, 196) had received a request for a lethal injection. Sixteen percent of the physicians receiving such requests (unweighted number, 42), or 3.3 percent of the entire sample, reported that they had written at least one prescripti...Continue Reading

References

Nov 5, 1992·The New England Journal of Medicine·T E QuillD E Meier
Aug 1, 1989·American Journal of Public Health·J B Jobe, D J Mingay
Jul 14, 1994·The New England Journal of Medicine·F G MillerD E Meier
Sep 30, 1993·The New England Journal of Medicine·T E Quill
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J DoukasJ Seid
Mar 1, 1995·American Journal of Public Health·N A Christakis, D A Asch
Feb 1, 1996·The New England Journal of Medicine·M A LeeS W Tolle
Feb 1, 1996·The New England Journal of Medicine·C J Ryan, M Kaye
Mar 27, 1996·JAMA : the Journal of the American Medical Association·A L BackR A Pearlman
Feb 6, 1997·The New England Journal of Medicine·L R SlomeD I Abrams
Jun 4, 1997·JAMA : the Journal of the American Medical Association·H HendinZ Zylicz
Jun 19, 1997·The New England Journal of Medicine·L Ganzini, M A Lee
Jul 3, 1997·The New England Journal of Medicine·M McKeogh
Aug 1, 1997·Annals of Internal Medicine·D E MeierC K Cassel
Nov 22, 1997·Journal of Clinical Epidemiology·D A AschN A Christakis

❮ Previous
Next ❯

Citations

Oct 31, 2006·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A MehnertU Koch
Oct 31, 2006·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·C Schmeling-Kludas
Jan 17, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F StiefelM Fegg
Jun 2, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ferraz Gonçalves
Oct 7, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·José António Ferraz Gonçalves
Aug 19, 2007·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Peter Kakuk
Sep 1, 2009·Journal of Bioethical Inquiry·Judith A C RietjensAgnes van der Heide
May 5, 2005·The Journal of Pediatrics·Astrid M VrakkingGerrit van der Wal
Dec 31, 2002·Lancet·Harvey Max ChochinovMike Harlos
Nov 17, 2001·Social Science & Medicine·T P DaalemanB B Frey
Feb 5, 2002·Social Science & Medicine·Harvey Max ChochinovMike Harlos
Aug 10, 2001·Journal of Pain and Symptom Management·T D WarnerS S Obenshain
Mar 31, 1999·Journal of Pain and Symptom Management·L GrassiM Ercolani
Jan 21, 2000·Journal of Pain and Symptom Management·J C Ahronheim, S B Davol
Apr 6, 2006·Palliative & Supportive Care·Kyriaki MystakidouLambros Vlahos
Sep 5, 2003·Psychology, Public Policy, and Law : an Official Law Review of the University of Arizona College of Law and the University of Miami School of Law·S Jamison
Mar 29, 2003·Psychology, Public Policy, and Law : an Official Law Review of the University of Arizona College of Law and the University of Miami School of Law·B Rosenfeld
Sep 7, 2006·Nature Clinical Practice. Oncology·Nathan I Cherny
Dec 14, 1999·Psychiatry and Clinical Neurosciences·T AkechiY Uchitomi
Dec 12, 2001·HIV Medicine·R AndraghettiM Borchert
Sep 19, 1998·The New England Journal of Medicine·H Hendin
Oct 1, 1998·The New England Journal of Medicine·L P Rowland
Feb 18, 1999·The New England Journal of Medicine·A E ChinD W Fleming
Feb 24, 2000·The New England Journal of Medicine·J H GroenewoudG van der Wal
Feb 24, 2000·The New England Journal of Medicine·L GanziniM A Lee
Feb 24, 2001·The New England Journal of Medicine·L A RoscoeD Cohen
Feb 8, 2002·The New England Journal of Medicine·Robert Steinbrook
May 14, 2004·The New England Journal of Medicine·Timothy E Quill
Jul 25, 2003·The New England Journal of Medicine·Linda GanziniMolly A Delorit
Feb 24, 2001·Hospital Topics·K Darr
Jan 11, 2013·Social Work in Health Care·Liam Ka-Po LauBetty Chung
Mar 4, 2005·Death Studies·James L Werth, Howard Wineberg
Apr 7, 2007·Death Studies·Helene StarksAshok J Bharucha
Sep 17, 2004·Journal of Health Communication·John C Pollock, Spiro G Yulis
Jul 23, 2002·Journal of Palliative Medicine·Tatsuya MoritaYumi Okazaki
Jan 22, 2004·Journal of Palliative Medicine·Ashok J BharuchaClarissa Hsu
Jan 22, 2004·Journal of Palliative Medicine·Harvey Max Chochinov
May 14, 2005·Journal of Palliative Medicine·Tomasz R Okon
Feb 28, 2006·Journal of Palliative Medicine·Harvey Max Chochinov, Beverley J Cann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.